SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028660
Filing Date
2021-11-15
Accepted
2021-11-15 16:38:02
Documents
38
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 374247
2 ex31-1.htm EX-31.1 17540
3 ex32-1.htm EX-32.1 6580
  Complete submission text file 0001493152-21-028660.txt   1855115

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20210930.xsd EX-101.SCH 16775
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT glsi-20210930_cal.xml EX-101.CAL 23663
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT glsi-20210930_def.xml EX-101.DEF 65206
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20210930_lab.xml EX-101.LAB 144360
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20210930_pre.xml EX-101.PRE 119604
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 169798
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 211411579
SIC: 2834 Pharmaceutical Preparations